ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO385

Risk of Target-Organ Damage in Pediatric Patients with CKD and Ambulatory Hypertension: A Systematic Review and Meta-Analysis

Session Information

Category: Hypertension and CVD

  • 1602 Hypertension and CVD: Clinical

Authors

  • Yu, Andrew, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
  • Chung, Jason, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada
  • Robinson, Cal, The Hospital for Sick Children, Toronto, Ontario, Canada
  • Dionne, Janis M., BC Children's Hospital, Vancouver, British Columbia, Canada
  • Parekh, Rulan S., Women's College Hospital, Toronto, Ontario, Canada
  • South, Andrew M., Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States
  • Mitsnefes, Mark, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
  • Noone, Damien Gerard, The Hospital for Sick Children, Toronto, Ontario, Canada
  • Chanchlani, Rahul, McMaster Children's Hospital, Hamilton, Ontario, Canada
Background

The objective of this systematic review is to determine the association of ambulatory hypertension and various ambulatory blood pressure monitoring (ABPM) parameters with left ventricular mass index (LVMI) in youth with CKD.

Methods

A systematic literature search on nine databases included English publications from 1974-2022. LVMI was indexed to subject height and body surface area (g/m2.7). Correlation coefficients were transformed and pooled using a random effects model. All stages of CKD were included for this review. Normative values of ABPM were derived from the German Working Group on Pediatric Hypertension.

Results

Of 1,128 screened studies, 16 studies and 2,254 children and adolescents were included. LVMI was elevated in the CKD hypertensive group compared to the CKD normotensive group (mean difference: 6.22 g/m2.7, 95% CI: 4.80-7.65). Youth with hypertension were at 3.34 (95% CI: 2.38-4.68) higher odds of left ventricular hypertrophy compared to normotensive children.

Conclusion

Pediatric CKD patients with ambulatory hypertension especially during nighttime were more likely to have higher LVMI and left ventricular hypertrophy. Adequate blood pressure control among children with CKD may be crucial to avoid the risk of target organ damage and future cardiovascular disease.